Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Holders of 5% or more of RCKT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Rocket Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Portfolio Management LLC | 13G | 5.35%5.85M shares | New | Jul 31, 20261 filing | Jul 31, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on Rocket Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 202611:40 AM ET | Vanguard Portfolio Management LLC | 13G | 5.35%5.85M shares | New | Jun 30, 2026 | SEC |
| Mar 27, 202612:59 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −7.89 ppfrom 7.89%Below 5% | Mar 13, 2026 | SEC |
| Feb 13, 20264:10 PM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 2.30%2.51M shares | −5.50 ppfrom 7.80%Below 5% | Dec 31, 2025 | SEC |
| Jan 30, 20262:46 PM ET | Vanguard Group Inc | 13G/A | 7.89%8.54M shares | – | Dec 31, 2025 | SEC |
| Aug 14, 20258:00 AM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 7.80%8.36M shares | +2.60 ppfrom 5.20% | Jun 30, 2025 | SEC |
| Jun 5, 20257:43 PM ET | Wellington Management Group LLPand 2 others | 13G/A | 0.90%1.00M shares | −5.80 ppfrom 6.70%Below 5% | May 30, 2025 | SEC |
| May 7, 202510:02 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 6.70%7.15M shares | −5.10 ppfrom 11.80% | Apr 30, 2025 | SEC |
| May 7, 20259:59 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 11.80%12.6M shares | −1.60 ppfrom 13.40% | Mar 31, 2025 | SEC |
| Apr 14, 20255:10 PM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G | 5.20%5.55M shares | New | Apr 7, 2025 | SEC |
| Feb 10, 202510:25 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 13.40%14.0M shares | – | Dec 31, 2024 | SEC |
| Mar 29, 2021 | RTW Investments, LP | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13GOld format | – | New | – | SEC |
| Jan 8, 2021 | RTW Investments, LP | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Rocket Pharmaceuticals, Inc. shares.
No Form 144 notices for Rocket Pharmaceuticals, Inc. are on file.